• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JXSB2100015 sacituzumab govitecan Injection Biological Products(2.2) Supplementary Application 2021-02-23 云顶药业(苏州)有限公司 Everest Medicines (Suzhou) Inc;Everest Medicines II(HK)Ltd;BSP Pharmaceuticals Srl In Review 2021-02-22 view
JXSL2100007 sacituzumab govitecan Injection Biological Products(2.2) Import Drug Application 2021-01-13 云顶药业(苏州)有限公司 Everest Medicines (Suzhou) Inc;Everest Medicines II(HK)Ltd In Review 2021-01-12 view
JXSL2000182 sacituzumab govitecan Injection Biological Products(2.2) Import Drug Application 2020-10-15 云顶药业(苏州)有限公司 Everest Medicines (Suzhou) Inc;Everest Medicines II(HK)Ltd In Review 2020-10-14 view
JXSL2000144 sacituzumab govitecan Injection Biological Products(2.2) Import Drug Application 2020-08-26 云顶药业(苏州)有限公司 Everest Medicines (Suzhou) Inc;Everest Medicines II(HK)Ltd In Review 2020-08-25 view
JXSL2000014 sacituzumab govitecan Injection Biological Products Import Drug Application 2020-01-22 云顶药业(苏州)有限公司 Everest Medicines (Suzhou) Inc;Everest Medicines II(HK)Ltd In Review 2020-01-21 view